期刊文献+

西吡氯铵与聚维酮碘含漱液对口腔念珠菌感染的疗效对照分析 被引量:21

Contrasting analysis on effect of cetylpyridinium chloride and povidone iodine on oral candidiasis
下载PDF
导出
摘要 目的对比西吡氯铵与聚维酮碘含漱液对口腔念珠菌感染的疗效及安全性。方法将83例口腔念珠菌感染患者随机分为2组,治疗组(n=42)给予西吡氯铵含漱液,对照组(n=41)给予聚维酮碘含漱液。比较2组患者口腔疼痛、黏膜萎缩、红斑评分,菌落数、镜检阳性率、综合疗效及不良反应的差异。结果 2组患者各症状评分均较治疗前显著改善,但治疗组改善幅度大于对照组;2组治疗后菌落数及真菌镜检阳性率均较治疗前显著下降,但2组之间无显著差异;治疗组显效率显著高于对照组,而2组总有效率之间无显著差异。治疗组未发生明显不适反应,对照组发生1例口腔黏膜充血。结论与聚维碘酮相比较,西吡氯铵含漱液对口腔念珠菌感染患者口腔疼痛、黏膜萎缩、红斑等症状的缓解作用更强,清除真菌的作用也有一定程度的提高,且安全性高,使用方便,具有临床推广价值。 Objective To contrast the effect and safety of cetylpyridinium chloride and povi- done iodine on oral candidiasis. Methods Eightythree patients with oral candidiasis were ran- domly divided into two groups. The treatment group ( n = 42) received cetylpyridinium chloride gargarism, and the control group (n = 41 ) received povidone iodine gargarism. The symptom seorings of oral pain, atrophic mucosa and erythema, colony count, positive rate by microscopy, com- prehensive effect and adverse reactions were compared. Results The symptom scorings in the two groups after treatment obviously improved, while the improving range in the treatment group was larger than that in the control group. The colony count and positive rate by microscopy decreased obviously after treatment, but there was no significant difference between the two groups. The sig- nificantly curative rate in the treatment group was obviously higher than that in the control group, but there was no significant difference of overall response rate between the two groups. There was no apparently adverse reaction in the treatment group, while there was 1 case of oral mucosal hyperemia in the control group. Conclusion Compared with povidone iodine, cetylpyridinium chloride has better effect on oral pain, atrophic mucosa and erythema. It has certain degree of improvement in clearing fungus, high safety, convenient usage, and value for clinical popularization.
作者 王燕
出处 《实用临床医药杂志》 CAS 2012年第21期118-120,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11220217)
关键词 西吡氯铵 聚维碘酮 含漱液 口腔念珠菌 cetylpyridinium chloride povidone iodine gargarism oral candidiasis
  • 相关文献

参考文献7

  • 1周小武,姜巍巍,毛利艳,梅丽琴.口腔念珠菌感染患者口内菌株检出情况和药敏性观察[J].中国全科医学,2012,15(14):1617-1619. 被引量:21
  • 2Rhodus N L.Treatment of oral candidiasis[J].NorthwestDent,2012,91(2):32.
  • 3SroussiH Y,Burke-Miller J,French A L,et al.Associationamong Vitamin D,Oral Candidiasis,and Calprotectinemia inHIV[J].Dent Res,2012,91(7):666.
  • 4Hu D,Li X,Sreenivasan PK,et al.A randomized,double-blind clinical study to assess the antimicrobial effects of acetylpyridinium chloride mouth rinse on dental plaque bacteria[J].Clin Ther,2009,31(11):2540.
  • 5Watanabe E,Tanomaru J M,Nascimento A P,et al.Deter-mination of the maximum inhibitory dilution of cetylpyridiniumchloride-based mouthwashes against Staphylococcus aureus:an in vitro study[J].J Appl Oral Sci,2008,16(4):275.
  • 6Nascimento A P,Tanomaru J M,Matoba-Júnior F,et al.Maximum inhibitory dilution of mouthwashes containingchlorhexidine and polyhexamethylene biguanide against salivaryStaphylococcus aureus[J].J Appl Oral Sci,2008,16(5):336.
  • 7Guzel A,Ozekinci T,Ozkan U,et al.Evaluation of the skinflora after chlorhexidine and povidone-iodine preparation inneurosurgical practice[J].Surgical Neurology,2009,71(2):207.

二级参考文献15

  • 1陈方淳,林梅.口腔念珠菌病患者口内菌株的检出和药敏性观察[J].华西口腔医学杂志,2007,25(1):37-41. 被引量:21
  • 2徐岩英 胡碧琼.含漱浓缩定量培养对口腔念珠菌病诊断价值的探讨[J].中华口腔医学杂志,1995,30:294-294.
  • 3XU Yan- ying, HU Bi - qiong, LIU Li -xin, et al. A study on the phenotype of Candida albicans isolated from the patients with oral can- didosis and healthy individuals [ J]. Chin J Stomatol, 1995, 30 (6) : 342.
  • 4National Committee for Clinical Laboratory Standards. Refereneemethod for broth dilution antifungal susceptibility testing of yeast. Approved standard M27- AZ2 [ S]. Pennsylvania, NCCLS, 2002, 22: 1- 29.
  • 5Mosquera J, Sharp A, Moore CB, Mine withitraconazole, fluconazole against Aspergillus spp [ J ]. J (2): 189-194. et al. In vitro interaction of terbin- amphotericin B and 5 - flucytosine Antimicrob Chemo~er, 2002, 50.
  • 6Pafller MA. Epidemiological typing methods for myeoses [ J]. Clin In- efet Dis, 1992:14 (Suppl): S4-S10.
  • 7Redding SW, Kirkpatriek WR, Dib O, et al. The epidemiology of non -albieans Candida in ogrpharyngeal candidiasis in HIV patients [ J ]. Spec Care Dentist, 2000, 20:178-181.
  • 8吴绍熙,郭宁如,廖万清.现代真菌病诊断治疗学[M].北京:中国协和医科大学出版社,1997:233.
  • 9Colombo AL, Barchiesi F, McGough DA, et al. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodi- lution method for azole antifungal susceptibility testing [J]. J Clin Mi- crobiol, 1995, 33 (3): 535-540.
  • 10Pflauer MA, Messer SA, Hollis R J, et al. In vitro activities of ravu- conazole andvoriconazole companed with those of four approved systemic antifungal agentsagainst 6970 clinical isolate of Candida spp [J]. An- timicrob A~ents Chemother. 2002. 46 (3) : 1723.

共引文献20

同被引文献121

引证文献21

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部